Scott Dunseth Myers Insider Profile
11 Followers
Scott Dunseth Myers, Director at Zentalis Pharmaceuticals, holds 395.89K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 0.00 shares in Dynavax (Ticker: DVAX), holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP).
Scott Dunseth Myers Zentalis Pharmaceuticals (ZNTL)Director
Zentalis Pharmaceuticals (ZNTL)
Director
Ranked #3,287 out of 109,193 Corporate Insiders
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
+64.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Dunseth Myers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 30, 2025 - Apr 30, 2026
Return:+182.30%
The most profitable trade made by Scott Dunseth Myers
Scott Dunseth Myers's Trading History
Zentalis Pharmaceuticals
Jun 18, 2026
Director
Uninformative Buy
―
$1.07M
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Harpoon Therapeutics
Mar 11, 2024
―
Uninformative Sell
―
$0.00
Cartesian Therapeutics
Dec 26, 2019
Director
Uninformative Buy
57.54K
$585.32K
Amag Pharmaceuticals
―
―
―
―
Trillium Therapeutics
―
―
―
―
Dynavax
Feb 10, 2026
―
Uninformative Sell
―
$0.00
Viridian Therapeutics
Apr 12, 2023
CEO, Director
Informative Buy
101.44K
$5.19M
List of latest transactions for each holding click on a transaction to see Scott Dunseth Myers's performance on stock
You May Also Like
Scott Dunseth Myers insider profile FAQ
What is the percentage of profitable transactions made by Scott Dunseth Myers?
The percentage of profitable transactions made by Scott Dunseth Myers is 50%.
What is the average return per transaction made by Scott Dunseth Myers?
The average return per transaction made by Scott Dunseth Myers is 64.20%.
What stocks does Scott Dunseth Myers hold?
Scott Dunseth Myers holds: ZNTL, CASC, HARP, RNAC, AMAG, ~TRIL, DVAX, VRDN stocks.
What was Scott Dunseth Myers’s latest transaction?
Scott Dunseth Myers latest transaction was an Uninformative Buy of ―.
What was Scott Dunseth Myers's most profitable transaction?
Scott Dunseth Myers’s most profitable transaction was an Informative Buy of ZNTL stock on April 30, 2025. The return on the trade was 182.30%.
What is Scott Dunseth Myers's role in Zentalis Pharmaceuticals?
Scott Dunseth Myers's role in Zentalis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.